Literature DB >> 27770230

Added value of smooth hypointense rim in the hepatobiliary phase of gadoxetic acid-enhanced MRI in identifying tumour capsule and diagnosing hepatocellular carcinoma.

Chansik An1, Hyungjin Rhee2, Kyunghwa Han1, Jin-Young Choi1, Young-Nyun Park2,3, Mi-Suk Park1, Myeong-Jin Kim1, Sumi Park4.   

Abstract

OBJECTIVES: To examine the added value of considering smooth hypointense rim in the hepatobiliary phase (HBP) of gadoxetic acid-enhanced MRI as capsule appearance for diagnosing tumour capsules and hepatocellular carcinoma (HCC).
METHODS: A total of 377 hepatic lesions (330 HCCs, 35 non-HCC malignancies and 12 benign) were included from 345 patients who underwent resection after MRI between January 2008 and December 2011. Two radiologists assessed the presence or absence of conventional capsule appearance and smooth hypointense rim in the HBP, and categorized each hepatic lesion according to the Liver Imaging Reporting and Data System. Difference in diagnostic performance was evaluated using the generalized estimating equation method.
RESULTS: For identifying capsule, the sensitivity and accuracy of HBP hypointense rim were significantly higher than those of conventional capsule appearance (81.5 % vs. 57.8 % and 76.1 % vs. 59.4 %, respectively; P < 0.001). For diagnosing HCC, the sensitivity and accuracy of LR-5 or LR-5 V were significantly higher when the HBP hypointense rim was also considered capsule appearance (83 % vs. 72.7 % and 84.1 % vs. 75.1 %, respectively; P < 0.001), with the same specificity (91.5 %).
CONCLUSIONS: Regarding smooth hypointense rim in the HBP as capsule appearance could improve the detection of tumour capsule and the diagnosis of HCC. KEY POINTS: • Identifying tumour capsule is important for diagnosis of hepatocellular carcinoma (HCC). • Gadoxetic acid-enhanced MRI provides hepatobiliary phase (HBP) images. • Smooth hypointense rim seen in HBP may represent tumour capsule. • Regarding smooth hypointense rim as capsule appearance may improve HCC diagnosis.

Entities:  

Keywords:  Diagnosis; Gadoxetic acid; Hepatocellular carcinoma; Magnetic resonance imaging; Sensitivity and specificity

Mesh:

Substances:

Year:  2016        PMID: 27770230     DOI: 10.1007/s00330-016-4634-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  18 in total

1.  Non-invasive diagnosis of hepatocellular carcinoma ≤ 2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI.

Authors:  Jordi Rimola; Alejandro Forner; Silvia Tremosini; Maria Reig; Ramón Vilana; Luis Bianchi; Carlos Rodríguez-Lope; Manel Solé; Carmen Ayuso; Jordi Bruix
Journal:  J Hepatol       Date:  2012-02-04       Impact factor: 25.083

2.  Differentiation of intrahepatic mass-forming cholangiocarcinoma from hepatocellular carcinoma on gadoxetic acid-enhanced liver MR imaging.

Authors:  Rihyeon Kim; Jeong Min Lee; Cheong-Il Shin; Eun Sun Lee; Jeong Hee Yoon; Ijin Joo; Seong Ho Kim; Inpyeong Hwang; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2015-09-15       Impact factor: 5.315

3.  Multidetector-row computed tomography (MDCT) for the diagnosis of hepatocellular carcinoma in cirrhotic candidates for liver transplantation: prevalence of radiological vascular patterns and histological correlation with liver explants.

Authors:  Angelo Luca; Settimo Caruso; Mariapina Milazzo; Giuseppe Mamone; Gianluca Marrone; Roberto Miraglia; Luigi Maruzzelli; Vincenzo Carollo; Marta Ida Minervini; Giovanni Vizzini; Salvatore Gruttadauria; Salvatore Grutttadauria; Bruno Gridelli
Journal:  Eur Radiol       Date:  2009-10-03       Impact factor: 5.315

4.  Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver.

Authors:  Asra S Khan; Hero K Hussain; Timothy D Johnson; William J Weadock; Shawn J Pelletier; Jorge A Marrero
Journal:  J Magn Reson Imaging       Date:  2010-08       Impact factor: 4.813

5.  Differentiation of hepatic hyperintense lesions seen on gadoxetic acid-enhanced hepatobiliary phase MRI.

Authors:  Young Joo Suh; Myeong-Jin Kim; Jin-Young Choi; Young Nyun Park; Mi-Suk Park; Ki Whang Kim
Journal:  AJR Am J Roentgenol       Date:  2011-07       Impact factor: 3.959

6.  Combined hepatocellular and cholangiocarcinoma (biphenotypic) tumors: imaging features and diagnostic accuracy of contrast-enhanced CT and MRI.

Authors:  Kathryn J Fowler; Arman Sheybani; Rex A Parker; Sean Doherty; Elizabeth M Brunt; William C Chapman; Christine O Menias
Journal:  AJR Am J Roentgenol       Date:  2013-08       Impact factor: 3.959

7.  Noninvasive diagnosis of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: can hypointensity on the hepatobiliary phase be used as an alternative to washout?

Authors:  Ijin Joo; Jeong Min Lee; Dong Ho Lee; Ju Hyeon Jeon; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2015-03-14       Impact factor: 5.315

8.  "Pseudo washout" sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumor.

Authors:  Kyung Won Doo; Chang Hee Lee; Jae Woong Choi; Jongmee Lee; Kyeong Ah Kim; Cheol Min Park
Journal:  AJR Am J Roentgenol       Date:  2009-12       Impact factor: 3.959

9.  Hepatocellular carcinoma with a pseudocapsule on gadolinium-enhanced MR images: correlation with histopathologic findings.

Authors:  Kousei Ishigami; Kengo Yoshimitsu; Yunosuke Nishihara; Hiroyuki Irie; Yoshiki Asayama; Tsuyoshi Tajima; Akihiro Nishie; Masakazu Hirakawa; Yasuhiro Ushijima; Daisuke Okamoto; Akinobu Taketomi; Hiroshi Honda
Journal:  Radiology       Date:  2008-12-18       Impact factor: 11.105

10.  Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images.

Authors:  Yusuhn Kang; Jeong Min Lee; Seung Ho Kim; Joon Koo Han; Byung Ihn Choi
Journal:  Radiology       Date:  2012-07-12       Impact factor: 11.105

View more
  9 in total

Review 1.  Pitfalls and problems to be solved in the diagnostic CT/MRI Liver Imaging Reporting and Data System (LI-RADS).

Authors:  Yeun-Yoon Kim; Jin-Young Choi; Claude B Sirlin; Chansik An; Myeong-Jin Kim
Journal:  Eur Radiol       Date:  2018-08-16       Impact factor: 5.315

2.  Capsule, septum, and T2 hyperintense foci for differentiation between large hepatocellular carcinoma (≥5 cm) and intrahepatic cholangiocarcinoma on gadoxetic acid MRI.

Authors:  Jiyoung Hwang; Young Kon Kim; Ji Hye Min; Seo-Youn Choi; Woo Kyung Jeong; Seong Sook Hong; Hyun-Joo Kim; Soohyun Ahn; Hyeon Seon Ahn
Journal:  Eur Radiol       Date:  2017-05-12       Impact factor: 5.315

3.  LI-RADS v2014 categorization of hepatocellular carcinoma: Intraindividual comparison between gadopentetate dimeglumine-enhanced MRI and gadoxetic acid-enhanced MRI.

Authors:  Ji Soo Song; Eun Jung Choi; Seung Bae Hwang; Hong Pil Hwang; HyeMi Choi
Journal:  Eur Radiol       Date:  2018-06-19       Impact factor: 5.315

Review 4.  MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.

Authors:  Ja Kyung Yoon; Jin-Young Choi; Hyungjin Rhee; Young Nyun Park
Journal:  Eur Radiol       Date:  2022-03-08       Impact factor: 7.034

Review 5.  Diagnosis of Hepatocellular Carcinoma with Gadoxetic Acid-Enhanced MRI: 2016 Consensus Recommendations of the Korean Society of Abdominal Radiology.

Authors: 
Journal:  Korean J Radiol       Date:  2017-04-03       Impact factor: 3.500

6.  The capsule appearance of hepatocellular carcinoma in gadoxetic acid-enhanced MR imaging: Correlation with pathology and dynamic CT.

Authors:  Bohyun Kim; Jei Hee Lee; Jai Keun Kim; Hye Jin Kim; Young Bae Kim; Dakeun Lee
Journal:  Medicine (Baltimore)       Date:  2018-06       Impact factor: 1.889

7.  Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017).

Authors:  Ying Ding; Sheng-Xiang Rao; Wen-Tao Wang; Cai-Zhong Chen; Ren-Chen Li; Mengsu Zeng
Journal:  Cancer Imaging       Date:  2018-12-07       Impact factor: 3.909

8.  The peritumoral hypointense rim around hepatocellular carcinoma on T2*-weighted magnetic resonance imaging: radiologic-pathologic correlation.

Authors:  Yoshinori Tsukahara; Yukinori Okajima; Akira Yamada; Masanobu Momose; Takeshi Uehara; Akira Shimizu; Yuji Soejima; Yasunari Fujinaga
Journal:  World J Surg Oncol       Date:  2021-02-06       Impact factor: 2.754

9.  Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging.

Authors:  Christoph J Zech; Ahmed Ba-Ssalamah; Thomas Berg; Hersh Chandarana; Gar-Yang Chau; Luigi Grazioli; Myeong-Jin Kim; Jeong Min Lee; Elmar M Merkle; Takamichi Murakami; Jens Ricke; Claude B Sirlin; Bin Song; Bachir Taouli; Kengo Yoshimitsu; Dow-Mu Koh
Journal:  Eur Radiol       Date:  2019-08-05       Impact factor: 5.315

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.